Biodesix, Inc. was founded in December 2005 by biotechnology entrepreneurs and researchers, eventually establishing its corporate headquarters and primary laboratory operations in Boulder and Louisville, Colorado. The enterprise operates as a data-driven diagnostic solutions company dedicated to discovering, developing, and commercializing innovative blood-based tests and advanced assays for the early detection, monitoring, and targeted treatment of lung cancer and other complex diseases.